Remuzzi G - Search Results

1

Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.

Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C. Macconi D, et al. Among authors: remuzzi g. J Lab Clin Med. 1989 May;113(5):549-60. J Lab Clin Med. 1989. PMID: 2541212

2

Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation.

Macconi D, Viganò G, Bisogno G, Galbusera M, Orisio S, Remuzzi G, Livio M. Macconi D, et al. Among authors: remuzzi g. Am J Kidney Dis. 1992 Apr;19(4):318-25. doi: 10.1016/s0272-6386(12)80447-1. Am J Kidney Dis. 1992. PMID: 1562019

3

Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.

Morigi M, Macconi D, Riccardi E, Boccardo P, Zilio P, Bertani T, Remuzzi G. Morigi M, et al. Among authors: remuzzi g. J Pharmacol Exp Ther. 1991 Aug;258(2):601-6. J Pharmacol Exp Ther. 1991. PMID: 1650836

4

Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.

Zoja C, Corna D, Macconi D, Zilio P, Bertani T, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. Lab Invest. 1990 Jan;62(1):34-40. Lab Invest. 1990. PMID: 1688634

5

Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and a thromboxane A2 analogue.

Zoja C, Orisio S, Perico N, Benigni A, Morigi M, Benatti L, Rambaldi A, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. Lab Invest. 1991 Jan;64(1):16-20. Lab Invest. 1991. PMID: 1703585

6

Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.

Zoja C, Perico N, Corna D, Benigni A, Gabanelli M, Morigi M, Bertani T, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. J Am Soc Nephrol. 1990 Nov;1(5):799-807. doi: 10.1681/ASN.V15799. J Am Soc Nephrol. 1990. PMID: 2133429

7

Role of platelet-activating factor in renal immune injury and proteinuria.

Perico N, Remuzzi G. Perico N, et al. Among authors: remuzzi g. Am J Nephrol. 1990;10 Suppl 1:98-104. doi: 10.1159/000168202. Am J Nephrol. 1990. PMID: 2256482 Review.

8

Abnormalities in arachidonic acid metabolites in nephrotoxic glomerular injury.

Zoja C, Perico N, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. Toxicol Lett. 1989 Mar;46(1-3):65-75. doi: 10.1016/0378-4274(89)90117-3. Toxicol Lett. 1989. PMID: 2495584 Review.

9

Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.

Zoja C, Benigni A, Livio M, Bergamelli A, Orisio S, Abbate M, Bertani T, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. Am J Pathol. 1989 May;134(5):1027-38. Am J Pathol. 1989. PMID: 2497648 Free PMC article.

10

A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.

Livio M, Macconi D, Morigi M, Orisio S, Benigni A, Patrono C, Remuzzi G. Livio M, et al. Among authors: remuzzi g. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:828-32. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2823570 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,532 results

Search Page

Filters